BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8081036)

  • 1. [Simultaneous radiotherapy and chemotherapy in the treatment of advanced cancer of the cervix uteri].
    Resbeut M; Noirclerc M; Viens P; d'Ercole C; Houvenaeghel G; Boubli L; Gamerre M; Delpéro JR
    Bull Cancer; 1993 Nov; 80(11):984-93. PubMed ID: 8081036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant chemoradiation prior to surgery in the treatment of advanced cervical carcinoma.
    Resbeut M; Cowen D; Viens P; Noirclerc M; Perez T; Gouvernet J; Delpero JR; Gamerre M; Boubli L; Houvenaeghel G
    Gynecol Oncol; 1994 Jul; 54(1):68-75. PubMed ID: 8020842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion].
    Lerouge D; Touboul E; Lefranc JP; Uzan S; Jannet D; Moureau-Zabotto L; Genestie C; Antoine M; Jamali M
    Cancer Radiother; 2004 Jun; 8(3):168-77. PubMed ID: 15217584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High complete response rate of concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervix.
    Lin JC; Ho ES; Jan JS; Yang CH; Liu FS
    Gynecol Oncol; 1996 Apr; 61(1):101-8. PubMed ID: 8626094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Simultaneous radiochemotherapy in locally advanced cancers of the cervix: a preliminary study].
    Delanian S; Housset M; Maulard-Durdux C; Taurelle R; Lecuru F; Baillet F
    Bull Cancer; 1995; 82(5):371-6. PubMed ID: 7626845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion.
    Huguet F; Cojocariu OM; Levy P; Lefranc JP; Darai E; Jannet D; Ansquer Y; Lhuillier PE; Benifla JL; Seince N; Touboul E
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1508-15. PubMed ID: 18676093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
    Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL
    Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot study of concurrent cisplatin, 5-fluorouracil, and external beam radiotherapy prior to radical surgery +/- intraoperative electron beam radiotherapy in locally advanced cervical cancer.
    Jurado M; Martínez-Monge R; García-Foncillas J; Azinovic I; Aristu J; López-García G; Brugarolas A
    Gynecol Oncol; 1999 Jul; 74(1):30-7. PubMed ID: 10385548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer.
    Kim YS; Shin SS; Nam JH; Kim YT; Kim YM; Kim JH; Choi EK
    Gynecol Oncol; 2008 Jan; 108(1):195-200. PubMed ID: 17963825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended-field radiotherapy and high-dose-rate brachytherapy in carcinoma of the uterine cervix: clinical experience with and without concomitant chemotherapy.
    Sood BM; Gorla GR; Garg M; Anderson PS; Fields AL; Runowicz CD; Goldberg GL; Vikram B
    Cancer; 2003 Apr; 97(7):1781-8. PubMed ID: 12655536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Locally advanced carcinoma of the cervix uteri (stage IIB-IIIB TNM-UICC): radiotherapy combined with simultaneous daily low-dose platinum. Phase II study].
    Micheletti E; La Face B; Bianchi E; Cagna E; Sartori E
    Radiol Med; 1996 May; 91(5):628-34. PubMed ID: 8693131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study.
    Chung YL; Jian JJ; Cheng SH; Hsieh CI; Tan TD; Chang HJ; Hung CF; Horng CF; Soong T; Tsou MH
    Gynecol Oncol; 2005 Apr; 97(1):126-35. PubMed ID: 15790448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent weekly cisplatin and radiotherapy in routine management of cervical cancer: a report on patient compliance and acute toxicity.
    Serkies K; Jassem J
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):814-21. PubMed ID: 15465198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent chemotherapy and hypofractionated twice-daily radiotherapy in cervical cancer patients with stage IIIB disease and bilateral parametrial involvement: a phase I-II study.
    Viegas CM; Araujo CM; Dantas MA; Froimtchuk M; Oliveira JA; Marchiori E; Souhami L
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1154-9. PubMed ID: 15519787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
    Morris M; Eifel PJ; Lu J; Grigsby PW; Levenback C; Stevens RE; Rotman M; Gershenson DM; Mutch DG
    N Engl J Med; 1999 Apr; 340(15):1137-43. PubMed ID: 10202164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative adjuvant concurrent chemoradiotherapy improves survival rates for high-risk, early stage cervical cancer patients.
    Ryu HS; Chun M; Chang KH; Chang HJ; Lee JP
    Gynecol Oncol; 2005 Feb; 96(2):490-5. PubMed ID: 15661240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study.
    Lanciano R; Calkins A; Bundy BN; Parham G; Lucci JA; Moore DH; Monk BJ; O'Connor DM
    J Clin Oncol; 2005 Nov; 23(33):8289-95. PubMed ID: 16230678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
    Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
    Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.